SCHEMBL8689398

SCHEMBL8689398

CCCCCNCCc1ccccc1-c1cn[nH]c1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.46
▸ ROCK2 O75116 9/20 0.42
▸ ROCK1 Q13464 4/20 0.42
▸ HTR1A P08908 1/20 0.40
▸ HTR1D P28221 1/20 0.40
▸ HTR1B P28222 1/20 0.40
▸ MPO P05164 1/20 0.38
▸ AKT1 P31749 1/20 0.37
▸ AKT2 P31751 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ BCL2L1 Q07817 1/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8688775 0.77 SIGMAR1 (0.46) SIGMAR1HTR1AHTR1DHTR1BMPO
SCHEMBL7256906 0.76 TRPA1 (0.55) ROCK2ROCK1AKT1AKT2BCL2L1
SCHEMBL8692355 0.74 SIGMAR1 (0.46) SIGMAR1HTR1AHTR1DHTR1BMPO
SCHEMBL30332929 0.70 DPP4 (0.55) ROCK2ROCK1AKT1AKT2BCL2L1
SCHEMBL3008829 0.68 SIGMAR1 (0.59) SIGMAR1
SCHEMBL3994288 0.68 CHRM2 (0.67) —
SCHEMBL30692269 0.67 MPO (0.59) SIGMAR1HTR1AMPO
SCHEMBL18761052 0.67 SIGMAR1 (0.49) SIGMAR1HTR1AHTR1DHTR1B
SCHEMBL21243264 0.67 SIGMAR1 (0.55) SIGMAR1MPO
SCHEMBL1325639 0.66 HTR2A (0.73) HTR1AHTR1DHTR1BMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807860-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS; HYPERLIPEMIA, ATHEROSCLEROSIS; ANTICHOLESTEROL AGENTS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-09-15 — — US disclosed
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 — — EP disclosed
Send feedback